The economic burden associated with time to therapy escalation for patients with atopic dermatitis uncontrolled with topical therapies

Atopic dermatitis (AD) patients uncontrolled on topical corticosteroids (TCS) wait variable durations before treatment escalation. While negative physical and psychosocial effects of this waiting are known, the economic burden is unknown. This real-world retrospective database study assessed whether time to therapy escalation among AD patients uncontrolled with topical agents impacts healthcare resource utilization (HCRU) or costs. Truven Health MarketScan Database data were analyzed from 01JAN2010 –30SEP2015 (identification period; IP).
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research